Presentation is loading. Please wait.

Presentation is loading. Please wait.

Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell (‘Berti’) lymphoma after administration of adalimumab 

Similar presentations


Presentation on theme: "Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell (‘Berti’) lymphoma after administration of adalimumab "— Presentation transcript:

1 Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell (‘Berti’) lymphoma after administration of adalimumab  Sarah M. Jacks, BA, Brent R. Taylor, MD, Raford P. Rogers, MD, Jonathan S. Ralston, MD, John S. Metcalf, MD, John Lazarchick, MD  Journal of the American Academy of Dermatology  Volume 71, Issue 3, Pages e86-e87 (September 2014) DOI: /j.jaad Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Primary aggressive CD8+ cytotoxic T-cell (Berti) lymphoma following adalimumab. Extremity with papulosquamous plaques clinically suggestive of psoriasis. Journal of the American Academy of Dermatology  , e86-e87DOI: ( /j.jaad ) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 Biopsy of an ulcer on the chest exhibited an epidermotropic CD8+ infiltrate of atypical T-cells. (Hematoxylin-eosin stain; original magnification ×10.) Journal of the American Academy of Dermatology  , e86-e87DOI: ( /j.jaad ) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell (‘Berti’) lymphoma after administration of adalimumab "

Similar presentations


Ads by Google